Recent developments include the appointment of a new CEO and strategic business agreements to support growth in core subsidiaries.

• Global Technologies appointed H. Wyatt Flippen as new CEO in February 2026 [N1].
• In September 2025, Primecare Supply entered into a Channel Partner Agreement with a third-party business development firm to support supplier and distribution relationships and technology platform management [S1].

The company’s proprietary technology platform for pharmaceutical procurement offers scalable infrastructure and recurring transaction-based revenue potential. Its strategic advisory services aim to build sustainable client businesses through measurable results, potentially fostering client trust and referral growth. The recent appointment of a new CEO may bring renewed strategic focus. Consolidation of resources from inactive subsidiaries into core operations could improve operational efficiency. The company’s focus on compliance and transparency may appeal to regulated healthcare clients.

Global Technologies Ltd faces significant liquidity constraints with a current ratio of 0.04 and a history of substantial net losses and stockholders' deficiency. The company operates in highly competitive markets with larger, established players possessing greater resources and brand recognition. Regulatory changes in healthcare and wellness sectors could increase compliance costs or restrict operations. The absence of patents and limited research and development investment may hinder innovation. The company’s limited operating history and small employee base present execution risks. Additional capital raises are necessary but uncertain, posing financial sustainability risks.

Global Technologies Ltd's competitive advantages stem from its proprietary Sinq Ops software platform used by Primecare Supply, which facilitates secure, compliant, and transparent pharmaceutical procurement workflows. The company's diversified product offerings and technology-enabled compliance provide differentiation in a highly competitive pharmaceutical distribution market. GTLL Advisory Group differentiates itself through a fiduciary-based, holistic advisory approach focused on measurable operational and financial improvements for clients in the wellness sector. However, the company operates in fragmented and competitive markets with larger, better-capitalized competitors, and holds no patents, which limits its intellectual property moat.

• Liquidity and Capital Risks: The company has limited cash and current assets relative to current liabilities, with a current ratio of 0.04 as of December 31, 2025. It anticipates needing to raise approximately $500,000 to fund operations through mid-2026. Failure to secure additional capital could impair operations and growth.
• Competitive Risks: Primecare Supply and GTLL Advisory operate in highly competitive markets with larger, better-capitalized competitors. Market entry barriers are moderate, and competitors may offer similar or superior products and services, potentially reducing market share and pricing power.
• Regulatory and Compliance Risks: Frequent changes in healthcare regulations, licensing standards, and pharmaceutical oversight could increase compliance costs or restrict product availability. Privacy, data security, and ethical use of technology are critical risks that may increase operational costs and regulatory scrutiny.
• Operational and Execution Risks: The company has a limited operating history and a small employee base, which may constrain its ability to scale operations effectively. The termination of the GOe3 acquisition reflects challenges in meeting operational milestones. Execution risks include managing growth, customer acquisition, and maintaining service quality.
• Technology and Innovation Risks: The company holds no patents and has not incurred research and development expenses recently. Rapid technological changes and emerging competitive platforms could render its offerings less relevant if it fails to adapt or innovate.

• Global Technologies Ltd is a multi-operational company incorporated in Delaware in 1999, with principal executive office in Greensboro, North Carolina.
• The company operates through wholly owned subsidiaries including Primecare Supply, LLC, GTLL Advisory Group, LLC, and 10 Fold Services, LLC (currently inactive).
• Primecare Supply, LLC is a B2B pharmaceutical procurement company launched in May 2025, using proprietary Sinq Ops software to connect licensed 503B pharmaceutical manufacturers with licensed medical clinics in the U.S., generating revenue on a per-transaction basis.
• Primecare Supply has contractual relationships with multiple 503B manufacturers, reseller partners, and hundreds of licensed medical clinics actively using its platform.
• GTLL Advisory Group, LLC, formed in May 2025, is a strategic consulting and advisory platform targeting small and mid-sized enterprises in the health and wellness sector, especially medical spas and wellness clinics. It had not commenced revenue operations as of fiscal 2025 but expected to start in fiscal 2026.
• 10 Fold Services, LLC was a strategic consulting and procurement agency focused on health and wellness sector go-to-market planning but ceased operations in June 2025 and transferred assets to Primecare Supply.
• The company terminated its acquisition of GOe3, LLC, an EV charging station network, in fiscal 2025 due to unmet milestones, reallocating resources to core health technology and advisory services.
• As of June 30, 2025, the company had zero patents and zero patents pending.
• The company had 2 full-time employees as of June 30, 2025, with no union representation and good employee relations.
• Financial snapshot as of 2025-12-31 shows cash and equivalents of $41,408, current assets of $41,408, current liabilities of $977,469, resulting in a current ratio of 0.04 and cash ratio of 0.04.
• Revenue for the period ending 2025-12-31 was $345,968, with a net loss of $144,760 and basic and diluted EPS of $0.
• The company has incurred significant losses historically, with an accumulated deficit of over $167 million as of June 30, 2025, and stockholders' deficiency of $1,153,279.
• Management anticipates the need to raise approximately $500,000 in additional capital to fund operations through June 30, 2026, primarily to support compliance and scale subsidiaries.
• Primecare Supply operates in a highly competitive pharmaceutical distribution and procurement industry, competing with licensed 503B manufacturers and third-party distributors.
• GTLL Advisory operates in a competitive professional services market targeting medical spas and wellness clinics, differentiating itself by a fiduciary-based, holistic advisory approach.
• The company faces risks from evolving regulatory environments, competition from larger firms, technological changes, and the need to maintain compliance and operational efficiency.
• The company has no research and development expenses recorded for fiscal years 2024 and 2025.
• Recent corporate development includes the appointment of a new CEO, H. Wyatt Flippen, announced in February 2026.
• Primecare Supply entered into a Channel Partner Agreement in September 2025 to support business development and expand supplier and distribution relationships.
• The company is subject to risks including liquidity constraints, competition, regulatory changes, cybersecurity threats, and the need to raise additional capital.
• The company’s website is www.globaltechnologiesltd.info, which provides access to SEC filings and other corporate information.